ESLA vs. BTSG
ESLA (Estrella Immunopharma Inc.) and BTSG (BrightSpring Health Services, Inc) are both stocks. Both are in the Healthcare sector — ESLA in Biotechnology, BTSG in Health Information Services. Over the past year, ESLA returned 8.70% vs 193.54% for BTSG. At a 0.07 correlation, their price movements are largely independent.
Performance
ESLA vs. BTSG - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ESLA achieves a -35.90% return, which is significantly lower than BTSG's 78.48% return.
ESLA
- 1D
- 7.05%
- 1M
- -13.79%
- YTD
- -35.90%
- 6M
- -34.21%
- 1Y
- 8.70%
- 3Y*
- -54.72%
- 5Y*
- —
- 10Y*
- —
BTSG
- 1D
- -0.54%
- 1M
- 14.26%
- YTD
- 78.48%
- 6M
- 76.92%
- 1Y
- 193.54%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
ESLA vs. BTSG - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
ESLA Estrella Immunopharma Inc. | -35.90% | 30.00% | -0.83% |
BTSG BrightSpring Health Services, Inc | 78.48% | 119.91% | 41.92% |
Correlation
The correlation between ESLA and BTSG is 0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.04 |
Correlation (All Time) Calculated using the full available price history since Jan 26, 2024 | 0.07 |
Fundamentals
ESLA:
$42.12M
BTSG:
$14.79B
ESLA:
-$0.35
BTSG:
$1.42
ESLA:
$0.00
BTSG:
$13.65B
ESLA:
$0.00
BTSG:
$1.66B
ESLA:
-$13.25M
BTSG:
$572.07M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ESLA vs. BTSG — Risk / Return Rank
ESLA
BTSG
ESLA vs. BTSG - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Estrella Immunopharma Inc. (ESLA) and BrightSpring Health Services, Inc (BTSG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ESLA | BTSG | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -4.78 | ||
| Sortino ratioReturn per unit of downside risk | -3.68 | ||
| Omega ratioGain probability vs. loss probability | 1.12 | 1.62 | -0.50 |
| Calmar ratioReturn relative to maximum drawdown | 0.12 | 10.86 | -10.74 |
| Martin ratioReturn relative to average drawdown | 0.20 | 36.86 | -36.66 |
Loading charts...
Drawdowns
ESLA vs. BTSG - Drawdown Comparison
The maximum ESLA drawdown since its inception was -96.58%, which is greater than BTSG's maximum drawdown of -35.56%. Use the drawdown chart below to compare losses from any high point for ESLA and BTSG.
Loading charts...
Drawdown Indicators
| ESLA | BTSG | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.58% | -35.56% | -61.02% |
Max Drawdown (1Y)Largest decline over 1 year | -70.13% | -17.93% | -52.20% |
Max Drawdown (3Y)Largest decline over 3 years | -96.58% | — | — |
Current DrawdownCurrent decline from peak | -95.29% | -0.54% | -94.75% |
Average DrawdownAverage peak-to-trough decline | -55.78% | -7.70% | -48.08% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 44.10% | 5.28% | +38.82% |
Volatility
ESLA vs. BTSG - Volatility Comparison
Estrella Immunopharma Inc. (ESLA) has a higher volatility of 18.90% compared to BrightSpring Health Services, Inc (BTSG) at 10.26%. This indicates that ESLA's price experiences larger fluctuations and is considered to be riskier than BTSG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ESLA | BTSG | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.90% | 10.26% | +8.64% |
Volatility (6M)Calculated over the trailing 6-month period | 72.06% | 29.18% | +42.88% |
Volatility (1Y)Calculated over the trailing 1-year period | 111.74% | 40.15% | +71.59% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 134.35% | 44.00% | +90.35% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 134.35% | 44.00% | +90.35% |
Dividends
ESLA vs. BTSG - Dividend Comparison
Neither ESLA nor BTSG has paid dividends to shareholders.
Financials
ESLA vs. BTSG - Financials Comparison
This section allows you to compare key financial metrics between Estrella Immunopharma Inc. and BrightSpring Health Services, Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ESLA and BTSG have a correlation of 0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ESLA has higher volatility (18.90%) compared to BTSG (10.26%). In terms of maximum drawdown, ESLA dropped -96.58% vs BTSG's -35.56%.
BTSG currently has the higher Sharpe Ratio (4.86 vs 0.08), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ESLA and BTSG
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer